RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,070,000 | -72.1% | 225,000 | -84.7% | 0.32% | -78.0% |
| Q2 2018 | $14,585,000 | +87.4% | 1,465,838 | 0.0% | 1.47% | +50.2% |
| Q1 2018 | $7,784,000 | -54.9% | 1,465,838 | -27.8% | 0.98% | -59.7% |
| Q4 2017 | $17,268,000 | -41.8% | 2,031,562 | 0.0% | 2.42% | -37.3% |
| Q3 2017 | $29,661,000 | -22.1% | 2,031,562 | 0.0% | 3.86% | -15.3% |
| Q2 2017 | $38,071,000 | -12.0% | 2,031,562 | 0.0% | 4.56% | -1.1% |
| Q1 2017 | $43,252,000 | +40.2% | 2,031,562 | 0.0% | 4.61% | +56.7% |
| Q4 2016 | $30,859,000 | – | 2,031,562 | – | 2.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|